Glucos Viaflo Baxter (Glucose)

Glucos Viaflo Baxter is an intravenous solution whose active ingredient is glucose. It is supplied as a sterile liquid for infusion, intended for use in clinical settings within the European Union. The product provides a source of carbohydrate that can be administered directly into the bloodstream to support patients who require rapid glucose supplementation.

Glucos Viaflo Baxter is used in medical practice to address short‑term needs for carbohydrate replacement. It may be employed in the following situations:

- Management of hypoglycemia when oral intake is not possible. - Provision of energy during peri‑operative fasting. - Support for patients receiving parenteral nutrition. - Treatment of electrolyte imbalances associated with low blood glucose. - Stabilisation of blood glucose levels in critically ill patients. - Adjunct therapy during fluid resuscitation when glucose is indicated.

Glucos Viaflo Baxter may cause a range of reactions, most of which are mild and transient. Serious adverse events are uncommon but should be monitored.

Common: - Mild hyperglycemia. - Local irritation at the infusion site. - Nausea or vomiting. - Headache. - Transient increase in serum osmolality.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reaction or anaphylaxis. - Electrolyte disturbances (e.g., hypernatremia). - Fluid overload in patients with cardiac or renal impairment.

When using Glucos Viaflo Baxter, clinicians should consider several safety measures to minimise risk. Important precautions include:

- Assess baseline blood glucose and monitor levels frequently during infusion. - Adjust dosage in patients with diabetes or impaired glucose tolerance. - Use caution in individuals with renal or cardiac failure due to risk of fluid overload. - Verify compatibility with other intravenous solutions before co‑administration. - Ensure proper aseptic technique to prevent infection. - Review patient history for known hypersensitivity to glucose solutions. - Document infusion rate and total volume administered.

Glucos Viaflo Baxter can interact with other medications or solutions, influencing its safety and effectiveness. Interaction considerations are:

Avoid: - Co‑administration with high‑dose insulin without close glucose monitoring. - Simultaneous infusion of hypertonic saline solutions that may exacerbate hypernatremia.

Use with caution: - Concurrent use of diuretics that affect fluid balance. - Medications that alter glucose metabolism, such as glucocorticoids. - Electrolyte‑containing IV fluids that may affect serum osmolality. - Drugs that cause hypoglycemia, requiring careful glucose level checks. - Parenteral nutrition formulations that already contain glucose.